Anti-aging : Individuals pursuing anti-aging benefits might start with a higher frequency of NAD injections , such as 1-2 times per week for several weeks, before reducing the frequency to a monthly or bi-monthly schedule
GIP and GLP1 are neuroprotective in preclinical models of neurodegenerative disease
other antioxidantsprevents the potential negative consequences of excessive antioxidant supplementation, which can paradoxically impair adaptations to exercise and normal immune function
A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis
Your BMI will fall into one of four categories, which helps providers assess your metabolic risk: Underweight: Under 18.5 Normal weight: 18.524.9 Overweight: 2529.9 Obesity: 30 or higher While BMI doesnt tell the full story (it doesnt account for muscle mass or fat distribution, for instance), it remains the primary clinical benchmark for determining GLP-1 eligibility
The dose escalation design tested different starting doses (2 mg vs 4 mg) to evaluate tolerability